Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia

This study presents a replicable UPLC-MS/MS method for the determination of quizartinib in plasma. The validated popPK model can be used to optimize dosing strategies in future clinical studies.

Authors

Institutions

Publication Details

Journal
European Journal of Clinical Pharmacology
Published
2025-08-30
DOI
https://doi.org/10.1007/s00228-025-03909-4
Citations
1
Primary Topic
Acute Myeloid Leukemia Research
Type
article
Field-Weighted Citation Impact
1.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia

Pau Montesinos, Rebeca Rodríguez‐Veiga, Eva Barragán, David Martínez‐Cuadrón et al.
1 citations
European Journal of Clinical Pharmacology
Acute Myeloid Leukemia Research
1.77
article

Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemia

Pau Montesinos, Rebeca Rodríguez‐Veiga, Eva Barragán, David Martínez‐Cuadrón, M Gil Candel, Juan Eduardo Megías‐Vericat, Jorge Labrador, Laura Torres-Miñana, Isabel Cano‐Ferri, Carles Iniesta Navalón, Pilar Lloret Madrid, Evelyn Acuña‐Cruz, José‐Esteban Peris, Blanca Boluda, Antonio Solana‐Altabella, Marina López‐Nogueroles, Irene Navarro-Vicente, José Luís Poveda, José Vicente Gil, Maria Choví-Trull, Mario Rodenas-Rovira
article en
1 citations

Abstract

This study presents a replicable UPLC-MS/MS method for the determination of quizartinib in plasma. The validated popPK model can be used to optimize dosing strategies in future clinical studies.

European Journal of Clinical PharmacologyVol. 81(11)
Universitat de València (ES), Hospital Universitari i Politècnic La Fe (ES), Hospital Universitario de Burgos (ES), Hospital Reina Sofía de Murcia (ES), Instituto de Investigación Sanitaria La Fe (ES), Universidad de Murcia (ES)
Fundación para la Investigación del Hospital Universitari La Fe, Instituto de Salud Carlos III
Openalex Percentile: Top 13%
Acute Myeloid Leukemia Research
1.77
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.